封面
市場調查報告書
商品編碼
1920926

2025-2029年癌症治療技術領域的成長機會

Growth Opportunities in Cancer Treatment Technologies, 2025-2029

出版日期: | 出版商: Frost & Sullivan | 英文 57 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

放射線治療和非放射線治療推動癌症治療的變革性發展

癌症治療技術在透過放射線治療和非放射線治療有效清除癌性腫瘤方面發揮著至關重要的作用。這些治療方法提供高度局部、微創/非侵入性和個人化的治療方案,有助於有效清除腫瘤。

全球癌症病例日益增多(主要原因是人們對癌症的認知不斷提高,以及能夠更早診斷的解決方案的出現),這正在加速這些技術的大規模應用。

醫療機構選擇這些治療方法是因為它們能夠在有效切除腫瘤的同時保護健康組織,從而改善患者的治療效果。

Frost & Sullivan的這項研究將癌症治療技術分為「放射線治療」和「非放射線治療」。放射線治療透過電離能破壞癌細胞的DNA來發揮作用,而非放射線治療則無需電離輻射即可殺死癌細胞。放射線治療包括生物導引放射線治療、近距離放射、自適應放射線治療、電子近距離放射療法和表淺放射線治療。非放射線治療包括組織溶解療法(聚焦超音波)、微波消融、水磨術、水熱蒸氣療法和用於腫瘤治療的電磁場療法。

目錄

戰略要務

  • 為什麼經濟成長變得越來越困難?
  • 策略要務八要素™:影響成長的因素
  • The Strategic Imperative 8(TM)
  • 三大策略要務對癌症治療產業的影響
  • 成長機會驅動Growth Pipeline Engine(TM)™
  • 調查方法

成長機會分析

  • 分析範圍
  • 按技術細分

成長泉

  • 成長要素
  • 成長限制因素

細分市場分析—放射腫瘤學

  • 放射治療概述
  • 放射腫瘤學主要企業- 主要創新
  • 其他放射治療創新者

細分市場分析—非放射線治療

  • 非放射線治療概述
  • 非放射線治療的主要企業- 主要創新
  • 其他非放射線治療創新者

資金籌措分析

  • 公共資金用於放射治療和非放射治療技術
  • 放射治療和非放射治療技術的私人資金
  • 放射治療和非放射治療技術的公共和私人資金

市場分析

  • 夥伴關係分析

專利狀態

  • 癌症治療技術專利分析
  • 主要專利

癌症治療技術領域的成長機會。

  • 成長機會 1:在癌症治療過程中應用人工智慧
  • 成長機會 2:多方向高能量敏捷掃描電子放射治療
  • 成長機會3:透過與契約製造組織合作外包醫療設備

附錄

  • 技術成熟度等級(TRL)解釋

未來發展

  • 成長機會帶來的益處和影響
  • 下一步
  • 免責聲明
簡介目錄
Product Code: DB31

Radiation and Non-radiation Therapies to Drive Transformational Growth in Cancer Management

Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.

The growing burden of cancer cases globally-primarily driven by increased awareness about the condition and the availability of solutions enabling early diagnosis-is accelerating large-scale adoption of these technologies.

Healthcare providers are opting for these therapies because they facilitate effective tumor removal while sparing healthy tissues, thereby improving patient outcomes.

This Frost & Sullivan research study categorizes cancer treatment technologies into radiation therapies, which work by delivering ionizing energy to damage the DNA of cancer cells, and non-radiation therapies, which kill cancer cells without ionizing radiation. Radiation therapy includes biology-guided radiotherapy, brachytherapy, adaptive radiation therapy, electronic brachytherapy, and superficial radiation therapy. Non-radiation therapy includes histotripsy (focused ultrasound), microwave ablation, aquablation, thermal water vapor therapy, and tumor treating fields.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™: Factors Creating Pressure on Growth
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Cancer Treatment Technologies Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation by Technologies

Growth Generator

  • Growth Drivers
  • Growth Restraints

Segment Analysis-Radiation Therapy

  • Radiation Therapy-Overview
  • Radiation Therapy Players-Key Innovations
  • Other Radiation Therapy Innovators

Segment Analysis-Non-radiation Therapy

  • Non-radiation Therapy-Overview
  • Non-radiation Therapy Players-Key Innovations
  • Other Non-radiation Therapy Innovators

Funding Analysis

  • Public Funding for Radiology and Non-radiology Therapy Technologies
  • Private Funding for Radiology and Non-radiology Therapy Technologies
  • Public and Private Funding for Radiology and Non-radiology Therapy Technologies

Market Analysis

  • Partnership Analysis

Patent Landscape

  • Patent Analysis for Cancer Treatment Technologies
  • Key Patents

Growth Opportunity Universe in Cancer Treatment Technologies

  • Growth Opportunity 1: Use of AI Across the Entire Cancer Care Continuum
  • Growth Opportunity 2: Pluridirectional High-Energy Agile Scanning Electronic Radiotherapy
  • Growth Opportunity 3: Medical Device Outsourcing Through Partnership with Contract Manufacturing Organizations

Appendix

  • Technology Readiness Levels (TRL): Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer